<DOC>
	<DOCNO>NCT02107469</DOCNO>
	<brief_summary>The purpose study determine whether phyllanthus niruri sida cordifolia effective treatment diabetic polyneuropathy compare placebo . Also two different administration form ( extract capsule crude herb ) use find whether difference efficiency compliance .</brief_summary>
	<brief_title>A Study Phyllanthus Niruri Sida Cordifolia Diabetic Peripheral Polyneuropathy</brief_title>
	<detailed_description>This study explore difference therapeutic efficiency modern extract whole drug powder Phyllanthus niruri plus Sida cordifolia root decoction diabetic neuropathy compare placebo . The difference compliance regard medicine food recommendation additionally document . Design - Study two part : Part I : prospective , placebo-controlled , partly double-blinded ( regard 2 arms- arm investigator-blinded ) , 3 arm-parallel group study 3 week Part II : prospective , investigator-blinded , long-term-study 8 week . The active group part I continue assigned medication placebo-patients part I randomize 2 group active medication . Methods : Symptoms assess use Neuropathy total symptom score 6 ( NTSS-6 ) main primary parameter . Additional quantitative sensory test do Neuropathy Analyzer Vibrotherm Dx Diabetic Footcare India detection vibration thermal sensation threshold . Tolerability , adverse drug reaction , Compliance regard medication intake dietary recommendation document additional questionnaire . Three randomize group 30 outpatient ( powder/decoction ; extract ; placebo ) create part I study first 3 week . At part I placebo group double blind compare extract group investigator-blinded powder/decoction group . After 3 week patient placebo group randomly assign active treatment group part II describe course treatment administration form 45 patient . Study visit prior 1,2,3,5 8 week . Statistical plan : The primary parameter compare Mann Whitney-U-Test . Secondary Parameters descriptively analyse . Implication : A new herbal formulation test diabetic neuropathy modern randomize placebo control study design Part I . The outcome observation part II bring u close evidence base selection different ayurvedic preparation upraise mark new extraction technology . Registry procedure quality factor : Data check compare data enter registry predefined rule range consistency data field registry . Source data verification ass accuracy , completeness , representativeness registry data compare data external data source ( medical record , paper case report form ) . Standard Operating Procedures address registry operation analysis activity , patient recruitment , data collection , data management , data analysis , report adverse event , change management . Sample size assessment specify number participant participant year necessary demonstrate effect . Statistical analysis plan describe analytical principle statistical technique employ order address primary secondary objective , specify study protocol plan .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Signed consent form positive history type 1 2 diabetes mellitus symptom diabetic neuropathy ( sensory , peripheral ) select . Only outpatient setting include . Patients â‰¥2 symptom least one symptom moderate severity occasional frequency ( 3 point NTSS6 ) include additionally show impaired vibration detection threshold . suffer associated clinical condition influence peripheral nerve function , example : peripheral vascular disease reason nerve damage vitamin deficiency ( FOL , B12 , E ) heavy metal intoxication ( especially lead , cadmium thallium ) intoxication ( alcohol , medicine ) infectious disease ( like HIV , typhus , syphilis , lyme disease , mononucleosis , ... ) cancer autoimmune disease hepatitis vasculitis amyloidosis severe kidney failure pregnancy disorder connective tissue steroid take 1 month prior study likely need insulin therapy Regarding prior medication patient advise start additional therapy study long symptoms worsening , antihyperglycaemic drug adjust study physician necessary .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Diabetic Polyneuropathy</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Polyneuropathy</keyword>
	<keyword>Ayurvedic</keyword>
	<keyword>Ayurveda</keyword>
	<keyword>Neuralgia</keyword>
	<keyword>Diabetic Neuralgia</keyword>
	<keyword>Sida cordifolia</keyword>
	<keyword>Phyllanthus Niruri</keyword>
	<keyword>Phyllanthus Amarus</keyword>
	<keyword>Extracts</keyword>
	<keyword>Extract</keyword>
	<keyword>Crude Herb</keyword>
	<keyword>Crude</keyword>
	<keyword>Herb</keyword>
	<keyword>Herbal</keyword>
	<keyword>Herbal Extract</keyword>
	<keyword>Decoction</keyword>
	<keyword>Churna</keyword>
	<keyword>Powder</keyword>
	<keyword>Bala</keyword>
	<keyword>Bhumyamalaki</keyword>
	<keyword>Tamalaki</keyword>
</DOC>